LEADARTIS  

Cancer therapeutics  

Sector

Biotech  

Stage

Proof of concept  

Funding needed

500 000 €  

Country

Spain  

Propietary technology that generates multivalent monoclonal antibodies

Two validated mechanisms of action with a single product

Intended for treatment of patients with different types of solid tumors

Possible superior antitumor efficacy and lower toxicity compared to current mAb technology

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar